21 May 2009
Non-skin malignancies after renal transplantation
S Lizakowski, A Dębska-Ślizień, B Imko-Walczuk, J Jaśkiewicz, B RutkowskiAnn Transplant 2009; 14(1): 56-56 :: ID: 880405
Abstract
Background: During the last several decades, renal transplantations (RT) have been performed with an increasing success. However, RT recipients are predisposed to greater number of late complications including neoplasia caused by graft-preserving immunosuppressive therapy. The objective of the research was to estimate the number and the type of de novo cancers among kidney grafts recipients.
Material/Methods: We reviewed medical records of 913 patients (568 males and 345 females) who underwent RT in our transplantation centre between 1980 and 2008.
Results: During the follow-up 30 (3.3%) RT recipients were diagnosed with
non-skin malignancies. 4 lymphomas and 26 solid malignancies were recognized (7 genitourinary, 5 lung, 4 gastrointestinal, 3 liver, 2 breast, 1 pancreas, 1 brain, 1 larynx, 1 suprarenal gland and 1 of unknown origin).Affected group included 23 (76%) males and 7 (24%) females, they mean age at diagnosis was 54.3±13 (range 24-79) years. The mean time since transplantation to cancer diagnosis was 66.2±58.9 (range 6-228) months. The immunosuppressive protocol consisted of: prednisone (P) azathioprine (AZA) cyclosporine A (CsA) in 14 (46%) patients, mycophenolate mofetil (MMF) tacrolimus (TAC) in 6 (20%) patients; CsA MMF in 4 (13%) patients, AZA in 1 (3.3%) patient; CsA in 3 (10%); TAC in 1 (3.3%) patient and TAC alone in 1 (3.3%) patient. Twelve (40%) patients died. All patients with lymphoma died (8-44 months after diagnosis). Four (13%) patients lost their grafts due to cancer.
Conclusions: Genitourinary cancer, lung cancer and lymphoma were diagnosed most frequently. Almost 50% of cancer patients received P, AZA and CsA. Life expectancy after cancer diagnosis was short.
Keywords: Kidney Transplantation
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860